CogT BEEM Study (a tDCS Study)

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 6, 2019

Primary Completion Date

January 19, 2022

Study Completion Date

January 19, 2022

Conditions
Mild Cognitive ImpairmentNeuropsychiatric Syndrome
Interventions
DEVICE

tDCS

tDCS (LPG/C3-anode, orbitofrontal cortex/Fp2-cathode) will be administered for 4 weeks (1 session per weekday for 2 weeks, and then 2 sessions per week for 2 weeks, for a total of 14 sessions). All subjects will receive anodal tDCS stimulation for 20 minutes per session, on C3 and the cathode electrode on Fp2 using 10/20 EEG system. tDCS will be applied with a pair of 35 cm2 single-use sponges soaked in approximately 4mL of saline solution on each side (\~8mL per sponge) connected to the stimulator. During the 20-minute tDCS session, we will use online tDCS design (i.e., a subject will simultaneously work on the visual attention-oriented task.

Trial Locations (1)

14642-0001

Cabin, Ur, Rochester

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Rochester

OTHER

NCT04099524 - CogT BEEM Study (a tDCS Study) | Biotech Hunter | Biotech Hunter